CTLA4 and autoimmune disease: Specifically, the CT60 A/G polymorphism impacts the expression levels of soluble CTLA-4, potentially enhancing susceptibility to autoimmune diseases by altering the ratio of transmembrane to soluble forms of the protein [29].